Preventing cervical cancer by vaccinating against HPV.
There was widespread media interest in a report on the successful results from a trial of a vaccine against virus strains responsible for cervical cancer. This article examines the background to the report, considers the actual outcomes and comments on the significance and likely impact of the vaccine.
Campbell
Ken
K
Leukaemia Research Fund.
D000293:Adolescent; D000328:Adult; D017326:Clinical Trials, Phase III as Topic; D005260:Female; D006801:Humans; D027383:Papillomaviridae / Q000276:immunology*; D030361:Papillomavirus Infections / Q000517:prevention & control*; D010919:Placebos; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control* / Q000821:virology; D014765:Viral Vaccines / Q000008:administration & dosage*
D010919:Placebos; D014765:Viral Vaccines